vs

Side-by-side financial comparison of ASHLAND INC. (ASH) and Pebblebrook Hotel Trust (PEB). Click either name above to swap in a different company.

ASHLAND INC. is the larger business by last-quarter revenue ($386.0M vs $345.7M, roughly 1.1× Pebblebrook Hotel Trust). ASHLAND INC. runs the higher net margin — -3.1% vs -5.3%, a 2.2% gap on every dollar of revenue. On growth, Pebblebrook Hotel Trust posted the faster year-over-year revenue change (7.9% vs -4.7%). Pebblebrook Hotel Trust produced more free cash flow last quarter ($114.5M vs $111.0M). Over the past eight quarters, Pebblebrook Hotel Trust's revenue compounded faster (-6.7% CAGR vs -18.1%).

Ashland, Inc., is an American chemical company headquartered in Wilmington, Delaware. The company began as an oil refinery in the city of Ashland, Kentucky, in 1924, before moving to Wilmington in 1994. The company has five wholly owned divisions, which include Chemical Intermediates and Solvents, composites, industrial specialties, personal and home care, pharmaceuticals, food and beverage, and agriculture. Until 2017, the company was the primary manufacturer of Valvoline.

Pebblebrook Hotel Trust is a publicly traded real estate investment trust (REIT) that owns, manages, and invests in upscale, luxury, and boutique hotel properties primarily across major urban and leisure destinations in the United States. Its portfolio caters to both business and leisure travelers, focusing on high-demand markets to deliver long-term value for stakeholders.

ASH vs PEB — Head-to-Head

Bigger by revenue
ASH
ASH
1.1× larger
ASH
$386.0M
$345.7M
PEB
Growing faster (revenue YoY)
PEB
PEB
+12.6% gap
PEB
7.9%
-4.7%
ASH
Higher net margin
ASH
ASH
2.2% more per $
ASH
-3.1%
-5.3%
PEB
More free cash flow
PEB
PEB
$3.5M more FCF
PEB
$114.5M
$111.0M
ASH
Faster 2-yr revenue CAGR
PEB
PEB
Annualised
PEB
-6.7%
-18.1%
ASH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ASH
ASH
PEB
PEB
Revenue
$386.0M
$345.7M
Net Profit
$-12.0M
$-18.4M
Gross Margin
27.2%
Operating Margin
-1.6%
2.3%
Net Margin
-3.1%
-5.3%
Revenue YoY
-4.7%
7.9%
Net Profit YoY
92.7%
31.8%
EPS (diluted)
$-0.26
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASH
ASH
PEB
PEB
Q1 26
$345.7M
Q4 25
$386.0M
$349.0M
Q3 25
$477.0M
$398.7M
Q2 25
$463.0M
$407.5M
Q1 25
$479.0M
$320.3M
Q4 24
$405.0M
$337.6M
Q3 24
$521.0M
$404.5M
Q2 24
$544.0M
$397.1M
Net Profit
ASH
ASH
PEB
PEB
Q1 26
$-18.4M
Q4 25
$-12.0M
$-17.9M
Q3 25
$31.0M
$-33.1M
Q2 25
$-742.0M
$18.1M
Q1 25
$31.0M
$-32.9M
Q4 24
$-165.0M
$-50.5M
Q3 24
$17.0M
$43.7M
Q2 24
$6.0M
$30.9M
Gross Margin
ASH
ASH
PEB
PEB
Q1 26
Q4 25
27.2%
Q3 25
33.3%
Q2 25
28.5%
Q1 25
30.7%
Q4 24
27.4%
Q3 24
33.2%
Q2 24
34.2%
Operating Margin
ASH
ASH
PEB
PEB
Q1 26
2.3%
Q4 25
-1.6%
2.5%
Q3 25
12.8%
-2.6%
Q2 25
-152.9%
12.9%
Q1 25
10.6%
-2.3%
Q4 24
-44.2%
-6.7%
Q3 24
6.1%
11.6%
Q2 24
-11.2%
15.4%
Net Margin
ASH
ASH
PEB
PEB
Q1 26
-5.3%
Q4 25
-3.1%
-5.1%
Q3 25
6.5%
-8.3%
Q2 25
-160.3%
4.4%
Q1 25
6.5%
-10.3%
Q4 24
-40.7%
-15.0%
Q3 24
3.3%
10.8%
Q2 24
1.1%
7.8%
EPS (diluted)
ASH
ASH
PEB
PEB
Q1 26
$-0.26
Q4 25
$-0.26
$-0.22
Q3 25
$0.83
$-0.37
Q2 25
$-16.21
$0.06
Q1 25
$0.65
$-0.37
Q4 24
$-3.50
$-0.47
Q3 24
$0.34
$0.24
Q2 24
$0.12
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASH
ASH
PEB
PEB
Cash + ST InvestmentsLiquidity on hand
$304.0M
$196.2M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$1.9B
$2.4B
Total Assets
$4.5B
$5.3B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASH
ASH
PEB
PEB
Q1 26
$196.2M
Q4 25
$304.0M
$184.2M
Q3 25
$215.0M
$223.2M
Q2 25
$207.0M
$256.1M
Q1 25
$168.0M
$208.1M
Q4 24
$219.0M
$206.7M
Q3 24
$300.0M
$134.0M
Q2 24
$399.0M
$101.7M
Total Debt
ASH
ASH
PEB
PEB
Q1 26
Q4 25
$1.4B
$2.1B
Q3 25
$1.4B
$2.2B
Q2 25
$1.4B
$2.2B
Q1 25
$1.3B
$2.2B
Q4 24
$1.3B
$2.2B
Q3 24
$1.3B
$2.2B
Q2 24
$1.3B
$2.2B
Stockholders' Equity
ASH
ASH
PEB
PEB
Q1 26
$2.4B
Q4 25
$1.9B
$2.5B
Q3 25
$1.9B
$2.5B
Q2 25
$1.9B
$2.6B
Q1 25
$2.6B
$2.6B
Q4 24
$2.6B
$2.7B
Q3 24
$2.9B
$2.8B
Q2 24
$3.0B
$2.7B
Total Assets
ASH
ASH
PEB
PEB
Q1 26
$5.3B
Q4 25
$4.5B
$5.3B
Q3 25
$4.6B
$5.6B
Q2 25
$4.6B
$5.7B
Q1 25
$5.2B
$5.7B
Q4 24
$5.2B
$5.7B
Q3 24
$5.6B
$5.7B
Q2 24
$5.7B
$5.7B
Debt / Equity
ASH
ASH
PEB
PEB
Q1 26
Q4 25
0.74×
0.86×
Q3 25
0.73×
0.89×
Q2 25
0.73×
0.85×
Q1 25
0.52×
0.85×
Q4 24
0.51×
0.83×
Q3 24
0.47×
0.80×
Q2 24
0.45×
0.80×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASH
ASH
PEB
PEB
Operating Cash FlowLast quarter
$125.0M
Free Cash FlowOCF − Capex
$111.0M
$114.5M
FCF MarginFCF / Revenue
28.8%
33.1%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$200.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASH
ASH
PEB
PEB
Q1 26
Q4 25
$125.0M
$249.7M
Q3 25
$40.0M
$77.6M
Q2 25
$115.0M
$90.5M
Q1 25
$9.0M
$50.3M
Q4 24
$-30.0M
$275.0M
Q3 24
$80.0M
$76.1M
Q2 24
$127.0M
$83.7M
Free Cash Flow
ASH
ASH
PEB
PEB
Q1 26
$114.5M
Q4 25
$111.0M
$152.3M
Q3 25
$6.0M
$6.8M
Q2 25
$95.0M
Q1 25
$-12.0M
Q4 24
$-53.0M
$146.3M
Q3 24
$42.0M
$-24.8M
Q2 24
$98.0M
FCF Margin
ASH
ASH
PEB
PEB
Q1 26
33.1%
Q4 25
28.8%
43.6%
Q3 25
1.3%
1.7%
Q2 25
20.5%
Q1 25
-2.5%
Q4 24
-13.1%
43.3%
Q3 24
8.1%
-6.1%
Q2 24
18.0%
Capex Intensity
ASH
ASH
PEB
PEB
Q1 26
Q4 25
3.6%
27.9%
Q3 25
7.1%
17.7%
Q2 25
4.3%
Q1 25
4.4%
Q4 24
5.7%
38.1%
Q3 24
7.3%
24.9%
Q2 24
5.3%
Cash Conversion
ASH
ASH
PEB
PEB
Q1 26
Q4 25
Q3 25
1.29×
Q2 25
5.01×
Q1 25
0.29×
Q4 24
Q3 24
4.71×
1.74×
Q2 24
21.17×
2.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASH
ASH

Personal Care And Household$123.0M32%
Other$120.0M31%
Specialty Additives$36.0M9%
Intermediates And Solvents$31.0M8%
Personal Care$30.0M8%
Life Sciences$27.0M7%
Intermediates$19.0M5%

PEB
PEB

Room$214.5M62%
Food and beverage$91.1M26%
Other$40.0M12%

Related Comparisons